ADC Therapeutics SA (ADCT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.04
Day's range
$4.22

Adc Therapeutics SA Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
REDMILE GROUP, LLC 02/17/2026 15.67 M $55.30 M   0.00% 11.48%
TCG CROSSOVER MANAGEMENT, LLC 02/17/2026 11.39 M $40.21 M   719.33% 8.35%
PROSIGHT MANAGEMENT, LP 02/13/2026 8.48 M $29.93 M   13.45% 6.21%
ORBIMED ADVISORS LLC 02/17/2026 5.82 M $20.55 M   -1.43% 4.27%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/13/2026 5.48 M $19.33 M   141.60% 4.01%
BLACKROCK, INC. 02/12/2026 5.43 M $19.16 M   20.29% 3.98%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 5.01 M $17.70 M   -38.36% 3.68%
MORGAN STANLEY 02/13/2026 3.77 M $13.31 M   2.74% 2.76%
EVENTIDE ASSET MANAGEMENT, LLC 02/13/2026 3.36 M $11.88 M   100.00% 2.47%
GOLDMAN SACHS GROUP INC 03/25/2026 1.64 M $5.79 M   2.91% 1.20%
STATE STREET CORP 02/13/2026 1.41 M $4.97 M   8.59% 1.03%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.30 M $4.58 M   -4.61% 0.95%
VANGUARD GROUP INC 01/29/2026 1.13 M $3.99 M   90.18% 0.83%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 996.52 K $3.52 M   15.48% 0.73%
PLATINUM INVESTMENT MANAGEMENT LTD 02/13/2026 990.78 K $3.50 M   -14.35% 0.73%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 830.90 K $2.93 M   20.69% 0.61%
BLUE OWL CAPITAL HOLDINGS LP 02/20/2026 733.57 K $2.93 M   0.00% 0.54%
VANTAGE CONSULTING GROUP INC 02/11/2026 683.00 K $2.41 M   0.00% 0.50%
PANAGORA ASSET MANAGEMENT INC 02/13/2026 594.26 K $2.10 M   9.19% 0.44%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 528.97 K $1.86 M   132.51% 0.39%
STEMPOINT CAPITAL LP 02/17/2026 502.57 K $1.77 M   77.41% 0.37%
JPMORGAN CHASE & CO 02/11/2026 471.69 K $1.67 M   42.68% 0.35%
VOLEON CAPITAL MANAGEMENT LP 02/17/2026 464.16 K $1.64 M   560.15% 0.34%
NORTHERN TRUST CORP 02/17/2026 437.55 K $1.54 M   4.79% 0.32%
SCHRODER INVESTMENT MANAGEMENT GROUP 02/13/2026 418.78 K $1.47 M   100.00% 0.31%
MILLENNIUM MANAGEMENT LLC 02/17/2026 328.43 K $1.16 M   -53.19% 0.24%
WELLS FARGO & COMPANY/MN 02/13/2026 320.05 K $1.13 M   360.49% 0.23%
CITADEL ADVISORS LLC 02/17/2026 298.22 K $1.05 M   -63.66% 0.22%
D. E. SHAW & CO., INC. 02/17/2026 263.07 K $928.64 K   100.00% 0.19%
UBS GROUP AG 01/29/2026 215.21 K $759.70 K   -17.94% 0.16%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 212.92 K $751.59 K   -14.86% 0.16%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 212.67 K $750.72 K   16.84% 0.16%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 206.58 K $729.21 K   42.22% 0.15%
JANE STREET GROUP, LLC 02/12/2026 199.76 K $705.17 K   -59.05% 0.15%
SQUAREPOINT OPS LLC 02/13/2026 173.87 K $613.75 K   -0.62% 0.13%
BANK OF NEW YORK MELLON CORP 02/10/2026 172.99 K $610.64 K   9.01% 0.13%
JUMP FINANCIAL, LLC 02/17/2026 162.25 K $572.74 K   1,299.79% 0.12%
BARCLAYS PLC 02/13/2026 161.39 K $569.69 K   23.71% 0.12%
FMR LLC 02/17/2026 133.80 K $472.30 K   0.28% 0.10%
TWO SIGMA ADVISERS, LP 02/17/2026 120.57 K $425.60 K   100.00% 0.09%
TWO SIGMA INVESTMENTS, LP 02/17/2026 119.46 K $421.70 K   162.79% 0.09%
NUVEEN, LLC 02/12/2026 118.92 K $419.77 K   -30.55% 0.09%
STATE OF WISCONSIN INVESTMENT BOARD 02/17/2026 113.37 K $400.19 K   100.00% 0.08%
CREATIVE PLANNING 02/17/2026 113.25 K $399.76 K   6.18% 0.08%
SANIBEL CAPTIVA TRUST COMPANY, INC. 01/20/2026 113.00 K $398.89 K   0.00% 0.08%
KINGSWOOD WEALTH ADVISORS, LLC 01/28/2026 105.00 K $370.65 K   100.00% 0.08%
BRYN MAWR TRUST CO 02/12/2026 100.00 K $353.00 K   0.00% 0.07%
CANTOR FITZGERALD, L. P. 02/17/2026 100.00 K $353.00 K   100.00% 0.07%
RHUMBLINE ADVISERS 02/13/2026 90.68 K $320.11 K   -9.74% 0.07%
XTX TOPCO LTD 02/17/2026 82.87 K $292.54 K   -9.51% 0.06%

Adc Therapeutics SA institutional Ownership - FAQ's

During the previous two years, 137 institutional investors and hedge funds held shares of Adc Therapeutics SA. The most heavily invested institutionals were:

BNP PARIBAS ARBITRAGE, SNC: 860,491

UBS Group AG: 458,902

WELLS FARGO & COMPANY/MN: 262,783

Russell Investments Group, Ltd.: 254,909

Bank of New York Mellon Corp: 202,254

Nuveen, LLC: 146,258

60.73% of Adc Therapeutics SA stock is owned by institutional investors.

Institutional investors have bought a total of 90.49 M shares in the last 24 months. This purchase volume represents approximately $381.87 M in transactions.